Kazuhiko Sugiyama, MD

Affiliations: 
Neurosurgery Hiroshima University, Higashihiroshima-shi, Hiroshima-ken, Japan 
Google:
"Kazuhiko Sugiyama"
Bio:

http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6TCB-4C718H2-193&_user=10&_coverDate=01/31/1992&_rdoc=1&_fmt=high&_orig=search&_origin=search&_sort=d&_docanchor=&view=c&_

Mean distance: 19.07 (cluster 24)
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Takami H, Satomi K, Fukuoka K, et al. (2021) Low tumor cell content predicts favorable prognosis in germinoma patients. Neuro-Oncology Advances. 3: vdab110
Ueda T, Namba M, Senoo T, et al. (2021) [An Autopsy Case of IGF‒Ⅱ Secreting Gastric Cancer with Non‒Islet Cell Tumor Hypoglycemia]. Gan to Kagaku Ryoho. Cancer & Chemotherapy. 48: 523-525
Yamasaki F, Nishibuchi I, Karakawa S, et al. (2021) T2-FLAIR Mismatch Sign and Response to Radiotherapy in Diffuse Intrinsic Pontine Glioma. Pediatric Neurosurgery. 1-9
Takano M, Kinoshita Y, Sugiyama K, et al. (2021) Detecting non-germinomatous germ cell tumor component by arterial spin labeling perfusion-weighted MR imaging in central nervous system germ cell tumor. European Journal of Radiology. 136: 109523
Onishi S, Amatya VJ, Karlowee V, et al. (2020) Radiological and Immunostaining Characteristics of H3.3 G34R-Mutant Glioma: A Report of 3 Cases and Review of the Literature. Pediatric Neurosurgery. 1-7
Takayasu T, Shah M, Dono A, et al. (2020) Cerebrospinal fluid ctDNA and metabolites are informative biomarkers for the evaluation of CNS germ cell tumors. Scientific Reports. 10: 14326
Sugiyama K. (2020) [Current Status and Future Perspectives of Adult Glioblastoma Treatment-My Thinkings during the Establishment of Brain Tumor Guidelines in Japan]. Gan to Kagaku Ryoho. Cancer & Chemotherapy. 47: 1020-1025
Narita Y, Nagane M, Mishima K, et al. (2020) Phase 1/2 Study of Tirabrutinib, a Second-Generation Bruton's Tyrosine Kinase Inhibitor, in Relapsed/Refractory Primary Central Nervous System Lymphoma. Neuro-Oncology
Onishi S, Amatya VJ, Kolakshyapati M, et al. (2020) Corrigendum to "T2-FLAIR mismatch sign in dysembryoplastic neuroepithelial tumor" [Eur. J. Radiol. 126 (2020) 108924]. European Journal of Radiology. 129: 109082
Takeishi Y, Takayasu T, Kolakshyapati M, et al. (2020) Advantage of high b value diffusion-weighted imaging for differentiation of common pediatric brain tumors in posterior fossa. European Journal of Radiology. 128: 108983
See more...